Salomón Z. Langer

18.8k total citations · 5 hit papers
242 papers, 15.3k citations indexed

About

Salomón Z. Langer is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Salomón Z. Langer has authored 242 papers receiving a total of 15.3k indexed citations (citations by other indexed papers that have themselves been cited), including 169 papers in Cellular and Molecular Neuroscience, 158 papers in Molecular Biology and 41 papers in Physiology. Recurrent topics in Salomón Z. Langer's work include Receptor Mechanisms and Signaling (110 papers), Neuroscience and Neuropharmacology Research (100 papers) and Neurotransmitter Receptor Influence on Behavior (67 papers). Salomón Z. Langer is often cited by papers focused on Receptor Mechanisms and Signaling (110 papers), Neuroscience and Neuropharmacology Research (100 papers) and Neurotransmitter Receptor Influence on Behavior (67 papers). Salomón Z. Langer collaborates with scholars based in France, Argentina and United States. Salomón Z. Langer's co-authors include S. Arbilla, Rita Raisman, Michael S. Briley, Margarita L. Dubocovich, N B Shepperson, Mike Briley, Dan Bylund, Robert J. Lefkowitz, J. Paul Hieble and R R Ruffolo and has published in prestigious journals such as Nature, Science and Journal of Biological Chemistry.

In The Last Decade

Salomón Z. Langer

241 papers receiving 14.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function.

1998 1.0k citations Salomón Z. Langer et al. profile →
International Union of Pharmacology nomenclature of adrenoceptors.

1994 1.0k citations Salomón Z. Langer et al. profile →
Presynaptic regulation of catecholamine release

1974 916 citations Salomón Z. Langer profile →
International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update.

1995 637 citations Salomón Z. Langer et al. profile →
International Union of Pharmacology. XV. Subtypes of γ-Aminobutyric AcidA Receptors: Classification on the Basis of Subunit Structure and Receptor Function

1998 515 citations Salomón Z. Langer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Salomón Z. Langer France	59	9.4k	8.3k	2.4k	1.5k	1.4k	242	15.3k
Perry B. Molinoff United States	58	6.8k 0.7×	7.2k 0.9×	1.9k 0.8×	1.2k 0.8×	787 0.6×	170	12.6k
Klaus Starke Germany	61	10.1k 1.1×	10.1k 1.2×	3.2k 1.3×	710 0.5×	934 0.7×	297	16.0k
Henry I. Yamamura United States	79	16.0k 1.7×	14.6k 1.7×	3.0k 1.3×	1.1k 0.7×	2.6k 1.9×	449	23.3k
Elliott Richelson United States	61	6.8k 0.7×	6.8k 0.8×	1.7k 0.7×	2.4k 1.6×	2.0k 1.5×	288	14.3k
B. Costall United Kingdom	64	8.5k 0.9×	5.2k 0.6×	1.5k 0.6×	1.3k 0.9×	1.4k 1.0×	307	13.3k
John R. Fozard Switzerland	44	5.5k 0.6×	5.1k 0.6×	2.4k 1.0×	796 0.5×	802 0.6×	165	11.1k
George R. Breese United States	71	10.8k 1.1×	6.0k 0.7×	2.2k 0.9×	1.5k 1.0×	990 0.7×	338	18.3k
David K. Grandy United States	67	11.6k 1.2×	9.8k 1.2×	2.8k 1.2×	1.3k 0.9×	666 0.5×	174	16.9k
Jacques Glowinski France	73	12.9k 1.4×	7.9k 0.9×	2.6k 1.1×	1.1k 0.7×	1.6k 1.2×	190	19.4k
Ian Creese United States	62	10.7k 1.1×	7.8k 0.9×	1.3k 0.5×	2.2k 1.5×	897 0.7×	158	14.7k

Countries citing papers authored by Salomón Z. Langer

Since Specialization

Citations

This map shows the geographic impact of Salomón Z. Langer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salomón Z. Langer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salomón Z. Langer more than expected).

Fields of papers citing papers by Salomón Z. Langer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salomón Z. Langer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salomón Z. Langer. The network helps show where Salomón Z. Langer may publish in the future.

Co-authorship network of co-authors of Salomón Z. Langer

This figure shows the co-authorship network connecting the top 25 collaborators of Salomón Z. Langer. A scholar is included among the top collaborators of Salomón Z. Langer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salomón Z. Langer. Salomón Z. Langer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Langer, Salomón Z.. (2015). α2-Adrenoceptors in the treatment of major neuropsychiatric disorders. Trends in Pharmacological Sciences. 36(4). 196–202. 44 indexed citations

Monti, Jaime M., D. Warren Spence, Seithikurippu R. Pandi‐Perumal, Salomón Z. Langer, & Rüdiger Hardeland. (2009). Pharmacotherapy of Insomnia: Focus on Zolpidem Extended Release. SHILAP Revista de lepidopterología. 1. 9 indexed citations

Mabjeesh, Nicola J., Sharon Biton, Sharon Engel, et al.. (2002). Unusual Alternative Splicing within the Human Kallikrein Genes KLK2 and KLK3 Gives Rise to Novel Prostate-specific Proteins. Journal of Biological Chemistry. 277(20). 18084–18090. 50 indexed citations

Langer, Salomón Z.. (1999). History and Nomenclature of α<sub>1</sub>-Adrenoceptors. European Urology. 36(Suppl. 1). 2–6. 41 indexed citations

Borg, Frank ter, Stephen O’Connor, S. Arbilla, et al.. (1995). UROSELECTIVE α1-ADRENOCEPTOR ANTAGONISTS FOR THE TREATMENT OF BENIGN PROSTATIC HYPERTROPHY. European Journal of Medicinal Chemistry. 30. 299s–310s. 8 indexed citations

Lefèvre-Borg, F, Stephen E. O'Connor, H. Schoemaker, et al.. (1993). Alfuzosin, a selective α₁‐adrenoceptor antagonist in the lower urinary tract. British Journal of Pharmacology. 109(4). 1282–1289. 69 indexed citations

Graham, David Y. & Salomón Z. Langer. (1992). Advances in sodium-ion coupled biogenic amine transporters. Life Sciences. 51(9). 631–645. 51 indexed citations

Galzin, Anne‐Marie, P Davous, M. Roudier, et al.. (1989). Platelet [3H]-imipramine binding is not modified in Alzheimer's disease. Psychiatry Research. 28(3). 289–294. 3 indexed citations

Sauvanet, J.-P., et al.. (1988). Imidazopyridines in sleep disorders : a novel experimental and therapeutic approach. Raven Press eBooks. 47 indexed citations

10.

Langer, Salomón Z. & Anne‐Marie Galzin. (1988). Studies on the serotonin transporter in platelets. Cellular and Molecular Life Sciences. 44(2). 127–130. 33 indexed citations

11.

Atkinson, Jeffrey, et al.. (1987). Effect of prolonged clonidine treatment and its withdrawal on noradrenaline turnover in the cerebral cortex and medulla oblongata of the spontaneously hypertensive rat. Naunyn-Schmiedeberg s Archives of Pharmacology. 336(1). 77–80. 10 indexed citations

12.

Galzin, Anne‐Marie & Salomón Z. Langer. (1986). Potentiation by deprenyl of the autoreceptor-mediated inhibition of [3H]-5-hydroxytryptamine release by 5-methoxytryptamine. Naunyn-Schmiedeberg s Archives of Pharmacology. 333(3). 330–333. 11 indexed citations

13.

Arbilla, S., et al.. (1985). Supersensitivity of α2-adrenoceptors modulating [3H]5-HT release after noradrenergic denervation with DSP4. European Journal of Pharmacology. 119(1-2). 131–133. 22 indexed citations

14.

Langer, Salomón Z. & Chantal Moret. (1982). Citalopram antagonizes the stimulation by lysergic acid diethylamide of presynaptic inhibitory serotonin autoreceptors in the rat hypothalamus.. Journal of Pharmacology and Experimental Therapeutics. 222(1). 220–226. 76 indexed citations

15.

Langer, Salomón Z. & N B Shepperson. (1982). Postjunctional α1- and α2-Adrenoceptors. Journal of Cardiovascular Pharmacology. 4. S8–S13. 37 indexed citations

16.

Pimoule, C. & Salomón Z. Langer. (1982). Duct ligation decreases [3H]clonidine binding in rat submaxillary glands. European Journal of Pharmacology. 82(1-2). 85–88. 4 indexed citations

17.

Raisman, Rita, Michael S. Briley, & Salomón Z. Langer. (1980). Specific tricyclic antidepressant binding sites in rat brain characterised by high-affinity 3H-imipramine binding. European Journal of Pharmacology. 61(4). 373–380. 204 indexed citations

18.

Cubeddu, L., Salomón Z. Langer, & N. Weiner. (1974). THE RELATIONSHIPS BETWEEN ALPHA RECEPTOR BLOCK, INHIBITION OF NOREPINEPHRINE UPTAKE AND THE RELEASE AND METABOLISM OF 3H-NOREPINEPHRINE. Journal of Pharmacology and Experimental Therapeutics. 188(2). 368–385. 29 indexed citations

19.

Li, Xiaotian, Elle M. Barnes, Salomón Z. Langer, & N. Weiner. (1974). RELEASE OF NOREPINEPHRINE AND DOPAMINE-β-HYDROXYLASE BY NERVE STIMULATION. I. ROLE OF NEURONAL AND EXTRANEURONAL UPTAKE AND OF ALPHA PRESYNAPTIC RECEPTORS. Journal of Pharmacology and Experimental Therapeutics. 190(3). 431–450. 13 indexed citations

20.

Langer, Salomón Z.. (1966). PRESENCE OF TONE IN THE DENERVATED AND IN THE DECENTRALIZED NICTITATING MEMBRANE OF THE SPINAL CAT AND ITS INFLUENCE ON DETERMINATIONS OF SUPERSENSITIVITY. Journal of Pharmacology and Experimental Therapeutics. 154(3). 674–674. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact